with acquired aplastic anaemia. Since then three other adult patients apparently suffering from aplastic anaemia have developed P.N.H.: in two the P.N.H. defect became severe and dominated the picture, while the fourth patient had a mild P.N.H. defect and died while the aplastic phase was still dominant. These cases have not been included in the series analysed above, although in their initial presentation they were indistinguishable from acquired aplastic anaemia. They are recorded here to draw attention to the fact that the possibility of the development of P.N.H. should perhaps be considered when the prognosis in aplastic anaemia is assessed.
Summary
In a 12-year period 60 patients suffering from chronic acquired aplastic anaemia have been investigated. In some cases the disease has run an acute course with death in weeks. Half the patients died within 15 months of onset. Eighteen are still alive but only six are in full remission, while another three are in partial remission with normal haemoglobin, with or without neutropenia, but with persistence of'thrombocytopenia. Invariably platelets have been the last component to return to normal, usually after a prolonged period.
Both sexes were equally affected, but the outlook may be more serious in patients over the age of 40 ; it was especially grave in a group of 16 patients who had profound neutropenia (fewer than 100/c.mm.) and severe thrombocytopenia (fewer than 20,000/c.mm.), but on the whole neutropenia did not materially affect prognosis to the same extent as did thrombocytopenia; death was usually due to haemorrhage rather than infection. In 22 cases bone-marrow aspiration showed normal or hyperplastic foci, but prognosis was little affected by this.
Evaluation of treatment is difficult, as spontaneous remissions may occur, but testosterone and corticosteroids in moderate doses can induce remissions in children near puberty. (Herbert and Zalusky, 1962) . In liver disease the enzymes concerned in the metabolic pathway of histidine degradation may be impaired, and reduced activity of one of these enzymes, Figlu transferase, may be responsible for the increased excretion of -Figlu in liver disease without folic-acid deficiency (Merritt, Rucknagel, Silverman, and Gardiner, 1962) . Knowles (1962) The results have been compared with those of the urinary xylose-excretion test, the value of which in the diagnosis of intestinal malabsorption is well established (Fourman, 1948 Gardner and Perez Santiago, 1956 ; Christiansen, Kirsner, and Ablaza, 1959) .
Methods and Material
Urinary Excretion of Figlu.-The determination of Figlu in the urine was performed as described by Kohn, Mollin, and Rosenbach (1961) , using electrophoresis on cellulose acetate strips. A 15-g. loading dose of L-histidine was given orally to the fasting patient. Urine was collected for five hours ; the period of collection beginning three hours after the dose of histidine. Table I (range 4.0 to 9.7 g.).
Patients
The results of the urinary Figlu-excretion estimations, the serum folic-acid and vitamin-B12 levels, and the haematological data are given in Table III.   TABLE III The urinary excretions of Figlu were abnormal in all of the 10 patients with idiopathic steatorrhoea tested before starting folic-acid therapy, as they were in all of the five patients with idiopathic malabsorption without steatorrhoea. In all the cases in which the serum folic-acid level was estimated it was below the normal range when the urinary excretion of Figlu was increased.
Ten patients with idiopathic steatorrhoea excreted less than 4 g. of xylose in five hours, including one (Case 7) who had been taking folic acid for a year prior to investigation and another (Case 13) who had received a short course of folic acid six months before the present study. Two patients (Cases 2 and 10) with normal xylose excretions had been taking folic acid for several weeks before the tests. Three of the five patients with idiopathic malabsorption without steatorrhoea had abnormal results for the urinary xylose test.
Case 22, with jejuno-ileitis, had abnormal xylose and Figlu results despite a normal faecal-fat excretion, as did Case 30 (scleroderma) and Case 32 (lymphosarcoma) with evidence of disease throughout the small bowel. The other two cases of lymphosarcoma, and the patient with chronic lymphocytic leukaemia, had steatorrhoea, low xylose excretions, and raised Figlu excretions. As in the cases of idiopathic malabsorption, the serum folic-acid activity was found to be low in all those patients with raised Figlu excretions in whom it was estimated. One patient (Case 21), however, showed transitional megaloblasts in the bone-marrow and had a low serum folic-acid level, but the urinary excretion of Figlu was normal. This is the only example in the series of a patient considered to be deficient of folic acid but having a normal Figlu test. Unfortunately results for the urinary xylose excretion and faecal fat estimation were not obtained.
The two patients (Cases 19 and 20) with regional enteritis limited to the terminal ileum had normal urinary Figlu and xylose results. The Figlu excretions were also normal in the group of patients with steatorrhoea following gastric surgery, but two (Cases 25 and 28) had urinary xylose excretions below the normal range.
Discussion
Impaired intestinal absorption of folic acid is virtually a constant feature of idiopathic steatorrhoea (Girdwood, 1953a; Chanarin, Anderson, and Mollin, 1958) . In the present study all of the cases of untreated idiopathic steatorrhoea had increased urinary excretions of Figlu, and the results of the serum folic-acid assays indicate that these were associated with folic-acid deficiency. The results therefore support the finding of Knowles (1962) that an abnormal Figlu excretion is the rule in idiopathic steatorrhoea.
Abnormal excretions of Figlu occur in a proportion of patients with megaloblastic anaemia due purely to vitamin-B,2
deficiency (Zalusky and Herbert, 1961 ; Knowles and Prankerd, 1962) , and so the demonstration of an increased excretion of Figlu does not assist in the recognition of patients with megaloblastic anaemia resulting from occult intestinal malabsorption.
The results of Knowles (1962) and of the present study indicate, however, that a normal Figlu test may be regarded as strong evidence against a diagnosis of idiopathic malabsorption.
The xylose-excretion test is often abnormal in those cases of intestinal malabsorption with disease of the jejunal mucosa. Its use has therefore been recommended for the diagnosis of idiopathic steatorrhoea (Christiansen et al., 1959 ; Fowler and Cooke, 1960) , tropical sprue (Gardner and Perez Santiago, 1956) , and regional enteritis with jejunal involvement (Shiner, Vakil, and Wilcox, 1962) .
Folic-acid deficiency resulting from intestinal malabsorption may be regarded as indicative of jejunal disease. The interpretation of an abnormal Figlu result in a patient with suspected small-bowel malabsorption is therefore assisted if considered together with the result of a xylose-excretion test. In the present series all of the untreated cases of idiopathic steatorrhoea had abnormal results for both these tests, as did three of the patients considered to have idiopathic malabsorption without steatorrhoea, and the cases of jejuno-ileitis due to Crohn's disease, intestinal scleroderma, and lymphomatous involvement of the small bowel.
The low xylose excretion in one of the patients (Case 28) with steatorrhoea following gastrojejunostomy and vagotomy was unexpected. This patient had severe iron-deficiency anaemia, and low xylose excretions have been reported in such cases (Wormsley, 1963) . Jejunal biopsy was not performed and " latent " idiopathic steatorrhoea aggravated by gastric surgery, as described by Paulley, Fairweather, and Leeming (1957) (Chanarin, Bennett, and Berry, 1962 Intestinal Malabsorption-Rose
BRIui not determined, but there was no haematological evidence of folic-acid deficiency. Kershaw and Girdwood (1964) found two out of six patients with disseminated carcinoma to have low serum folic-acid levels and increased Figlu excretions, and Girdwood (1953b) has reported evidence of folic-acid deficiency in this condition. The most likely explanation for such cases is that there is an increased demand for folic acid due to the proliferation of malignant cells. Dymock (1964a) has estimated the urinary excretion of urocanic acid and Figlu in 28 patients with malignant disease, and in 24 the outputs were abnormal. He did not measure the serum folic-acid levels, and in 10 cases there was some evidence of liver dysfunction (Dymock, 1964b) . It is possible, therefore, that in some cases of disseminated malignancy the abnormal Figlu excretion results from an impairment of hepatic Figlu transferase activity. A rapid turnover of folic acid may have contributed to the folic-acid deficiency observed in the three patients with lymphosarcoma and the patient with chronic lymphocytic leukaemia. Abnormal Figlu excretions occur frequently in both acute and chronic leukaemias and reticuloses, and in such cases the serum folic-acid levels are often low (Rose, 1964 
